{"id":24876,"date":"2025-02-20T07:09:02","date_gmt":"2025-02-20T06:09:02","guid":{"rendered":"https:\/\/k2info.w.uib.no\/?p=24876"},"modified":"2025-02-20T07:09:02","modified_gmt":"2025-02-20T06:09:02","slug":"bridging-nordic-atmps-webinarserie","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2025\/02\/20\/bridging-nordic-atmps-webinarserie\/","title":{"rendered":"[:no]Bridging Nordic ATMPs \u2013 webinarserie[:en]Bridging Nordic ATMPs \u2013 webinar series[:]"},"content":{"rendered":"<p>[:no]Det neste EATRIS-webinaret vil finne sted 12. mars kl. 12.00 CET med David Morrow, EATRIS Senior Program Manager som snakker om &laquo;EATRIS&#8217; rolle i utviklingen av neste generasjon av celle- og genterapier&raquo;. David er plattformsjef for plattformene <a href=\"https:\/\/eatris.eu\/atmp\/\">Advanced Therapy Medicinal Products (ATMP)<\/a> og <a href=\"https:\/\/eatris.eu\/vaccines\/\">Vaccines, Inflammation and Immune Monitoring (VIIM).<\/a><\/p>\n<blockquote class=\"wp-embedded-content\" data-secret=\"fsOze1oglY\"><p><a href=\"https:\/\/eatris.eu\/events\/bridging-nordic-atmps-webinar-series-2\/\">Bridging Nordic ATMPs &#8211; webinar series<\/a><\/p><\/blockquote>\n<p><iframe loading=\"lazy\" class=\"wp-embedded-content\" sandbox=\"allow-scripts\" security=\"restricted\" style=\"position: absolute; visibility: hidden;\" title=\"&#8220;Bridging Nordic ATMPs &#8211; webinar series&#8221; &#8212; EATRIS\" src=\"https:\/\/eatris.eu\/events\/bridging-nordic-atmps-webinar-series-2\/embed\/#?secret=8i6ubh5uNl#?secret=fsOze1oglY\" data-secret=\"fsOze1oglY\" width=\"600\" height=\"338\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\"><\/iframe><\/p>\n<p><a href=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-24877\" src=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png\" alt=\"\" width=\"785\" height=\"384\" srcset=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png 785w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-300x147.png 300w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-768x376.png 768w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-624x305.png 624w\" sizes=\"auto, (max-width: 785px) 100vw, 785px\" \/><\/a>[:en]The next EATRIS webinar will take place on 12 March at 12.00 CET featuring <strong>David Morrow, EATRIS Senior Programme Manager <\/strong>speaking on <strong>\u201c<em>The role of EATRIS in developing the next generation of Cell and Gene Therapies\u201d<\/em>. <\/strong>David is the Platform Manager of the <a href=\"https:\/\/eatris.eu\/atmp\/\">Advanced Therapy Medicinal Products (ATMP)<\/a> and <a href=\"https:\/\/eatris.eu\/vaccines\/\">Vaccines, Inflammation and Immune Monitoring (VIIM)<\/a> Platforms.<\/p>\n<p><a href=\"https:\/\/eatris.eu\/events\/bridging-nordic-atmps-webinar-series-2\/\">https:\/\/eatris.eu\/events\/bridging-nordic-atmps-webinar-series-2\/<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-24877\" src=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png\" alt=\"\" width=\"785\" height=\"384\" srcset=\"https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat.png 785w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-300x147.png 300w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-768x376.png 768w, https:\/\/k2info.w.uib.no\/files\/2025\/02\/eat-624x305.png 624w\" sizes=\"auto, (max-width: 785px) 100vw, 785px\" \/><\/a>[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no]Det neste EATRIS-webinaret vil finne sted 12. mars kl. 12.00 CET med David Morrow, EATRIS Senior Program Manager som snakker om &laquo;EATRIS&#8217; rolle i utviklingen av neste generasjon av celle- og genterapier&raquo;. David er plattformsjef for plattformene Advanced Therapy Medicinal&hellip;<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/nb_no\/2025\/02\/20\/bridging-nordic-atmps-webinarserie\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":5375,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[],"class_list":["post-24876","post","type-post","status-publish","format-standard","hentry","category-nyheter"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/24876","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/5375"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=24876"}],"version-history":[{"count":1,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/24876\/revisions"}],"predecessor-version":[{"id":24878,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/24876\/revisions\/24878"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=24876"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=24876"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=24876"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}